As the ASX200 reached an all-time intra-day high of 8,827 points, the Australian market demonstrated robust performance with Materials, Energy, and Real Estate sectors leading the charge. Amidst this backdrop of strong market activity, penny stocks—often seen as relics from past eras—continue to offer intriguing opportunities for investors seeking growth at lower price points. These stocks typically represent smaller or newer companies and can provide potential upside when backed by solid financial health and fundamentals. Top 10 Penny Stocks In Australia Name Share Price Market Cap Financial Health Rating Alfabs Australia (ASX:AAL) A$0.40 A$114.64M ★★★★☆☆ EZZ Life Science Holdings (ASX:EZZ) A$2.36 A$111.33M ★★★★★★ GTN (ASX:GTN) A$0.375 A$71.5M ★★★★★★ IVE Group (ASX:IGL) A$2.90 A$447.13M ★★★★★☆ West African Resources (ASX:WAF) A$2.61 A$2.98B ★★★★★★ Southern Cross Electrical Engineering (ASX:SXE) A$1.82 A$481.22M ★★★★★★ Regal Partners (ASX:RPL) A$3.05 A$1.03B ★★★★★★ Austco Healthcare (ASX:AHC) A$0.385 A$140.68M ★★★★★★ CTI Logistics (ASX:CLX) A$1.85 A$149.01M ★★★★☆☆ Reckon (ASX:RKN) A$0.61 A$69.11M ★★★★☆☆ Click here to see the full list of 456 stocks from our ASX Penny Stocks screener. Let's explore several standout options from the results in the screener. Bisalloy Steel Group Simply Wall St Financial Health Rating: ★★★★★★ Overview: Bisalloy Steel Group Limited manufactures and sells quenched and tempered, high-tensile, and abrasion-resistant steel plates in Australia, Indonesia, Thailand, and internationally with a market cap of A$200.71 million. Operations: The company's revenue is primarily generated from its operations in Australia, amounting to A$103.30 million. Market Cap: A$200.71M Bisalloy Steel Group presents a mixed picture for penny stock investors. The company has demonstrated stable earnings growth, averaging 19.3% annually over the past five years, although recent growth has slowed to 14%, aligning with industry trends. Its financial health is bolstered by more cash than debt and strong operating cash flow coverage of its debt at 900.9%. Additionally, Bisalloy's return on equity stands at a high 21.7%, and its short-term assets comfortably cover both short- and long-term liabilities. However, potential investors should be cautious of an unstable dividend track record and recent volatility in profit margins despite improvements over the past year. Click here and access our complete financial health analysis report to understand the dynamics of Bisalloy Steel Group. Gain insights into Bisalloy Steel Group's outlook and expected performance with our report on the company's earnings estimates. Story Continues ASX:BIS Revenue & Expenses Breakdown as at Aug 2025 Emerald Resources Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Emerald Resources NL is involved in the exploration and development of mineral reserves in Cambodia and Australia, with a market capitalization of A$2.32 billion. Operations: The company generates revenue primarily from its Mine Operations segment, which accounted for A$427.32 million. Market Cap: A$2.32B Emerald Resources offers intriguing prospects for penny stock investors with its robust financial health and strategic growth initiatives. The company's earnings are forecasted to grow at 36% annually, supported by high-quality earnings and a strong balance sheet where short-term assets exceed liabilities. Its interest payments are well covered by EBIT, indicating sound debt management, while operating cash flow comfortably covers its debt levels. Although the Return on Equity is relatively low at 15.6%, Emerald's seasoned management team and board provide stability. Recent production guidance updates reveal ambitious gold output targets from the Okvau Gold Mine, signaling potential future revenue growth. Jump into the full analysis health report here for a deeper understanding of Emerald Resources. Review our growth performance report to gain insights into Emerald Resources' future.ASX:EMR Debt to Equity History and Analysis as at Aug 2025 Kairos Minerals Simply Wall St Financial Health Rating: ★★★★★★ Overview: Kairos Minerals Limited, with a market cap of A$71.03 million, is a resource exploration company operating in Australia through its subsidiaries. Operations: Kairos Minerals Limited does not report any specific revenue segments. Market Cap: A$71.03M Kairos Minerals, with a market cap of A$71.03 million, is a pre-revenue resource exploration company in Australia. The management and board are experienced, each with an average tenure of 3.3 years, providing stability in leadership. Despite being unprofitable and having high volatility compared to most Australian stocks, Kairos has managed to reduce its losses by 24.9% annually over the past five years and remains debt-free for the last five years. The company's short-term assets significantly cover both its short-term and long-term liabilities, ensuring financial resilience amidst ongoing exploration activities. Click here to discover the nuances of Kairos Minerals with our detailed analytical financial health report. Gain insights into Kairos Minerals' historical outcomes by reviewing our past performance report.ASX:KAI Financial Position Analysis as at Aug 2025 Turning Ideas Into Actions Navigate through the entire inventory of 456 ASX Penny Stocks here. Looking For Alternative Opportunities? These 19 companies survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. Discover why before your portfolio feels the trade war pinch. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ASX:BIS ASX:EMR and ASX:KAI. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected] View Comments
ASX Penny Stocks To Watch In August 2025
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...